Header for print stylesheet
You are here:  

Formulation and Development

DSM Pharmaceuticals, Inc., Formulation Development and CTM Manufactur¬ing services have offerings to include Formulation Development and Clinical Trial Manufacturing for solid dosage form products. Averaging over 20 product launch¬es per year, DSM has a 37 year history of successfully manufacturing complex solid dosage forms for the commercial pharmaceutical market. These services have significant value-added benefits to our customers in terms of reducing cost and accelerating time to market. They will be able to avoid the high cost of tech transfers leading to launch and commercial supply. Our services are supported by a staff of Scientists and Project Managers dedicated exclusively to these services.

Innovative Development Solutions

• Preformulation studies
• Formulation development
• CTM manufacturing
• Stability studies
• Evaluation of new delivery technologies
• Formula and process optimization through DOE

Preformulation Services

•  Physico-chemical characterization of drug substance
•  Polymorphism studies
•  Powder X-ray diffraction
•  Qualitative and quantitative thermal analysis
•  Solubility and partitioning studies
•  Salt form selection
•  Excipient compatibility studies
•  Packaging compatibility and extractability studies
•  Forced degradation studies

Formulation Services

•  Tablets, capsules, liquids, suspensions and semi-solids
•  Reformulations and line extensions
•  Modified and controlled release tablets and capsules
•  Controlled substance (Schedule I-III)
•  Evaluation of packaging presentations based on formulation requirements
•  Bottle, blister, sachet and tube packaging
•  Clinical supply and placebo manufacture Phase I-III
•  Review of batch documentation by Quality Assurance team

Analytical Research Support

•  Method development and validation for Phase I-III
•  Process development support and release testing
•  Cleaning validations for manufacturing equipment
•  Non-compendial method development and validation
•  Drug substance impurity profiling (HPLC)
•  Dissolution studies (ICH guidelines and customer design)
      -  Validated environmental chambers
      -  25C/60%RH, 30C/65%RH
      - 40C/75%RH, 25C/40%RH
      - 40C/25%RH, 5C, photostability
•  Microbiological methods validation and testing method development and testing
•  Stability

Modern Laboratory Facilities

•  Formulation development 3,000 sq. ft.
•  Analytical development of 27,000 sq. ft.
•  Process development and CTM manufacturing 30,000 sq. ft.





Submit an inquiry and download fact sheet (249 KB)

Pharmaceuticals
+1 252 707 4376
info.dsmpharmaceuticals@dsm.com

footer for print stylesheet